Search

everythinglearnresearchcommunity

for

Search:↓

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Targeting colon cancer stem cells might lead to better treatment results.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Dutasteride may help shrink prostate cancer tumors.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Vertex pattern hair loss linked to higher prostate cancer risk.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

SCDSFs from zebrafish embryos are beneficial for treating cancer, regenerating tissues, and improving conditions like psoriasis and alopecia.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.